GNFT Quote, Financials, Valuation and Earnings

Cellectis SA has a net margin of -- compared to Genfit SA's net margin of 46.57%. Genfit SA's return on equity of -- beat Cellectis SA's return on equity of -31.46%.

Genfit SA has a consensus price target of $10.17, signalling upside risk potential of 186.94%. On the other hand Cellectis SA has an analysts' consensus of $5.80 which suggests that it could grow by 356.69%. Given that Cellectis SA has higher upside potential than Genfit SA, analysts believe Cellectis SA is more attractive than Genfit SA.

Genfit SA has a beta of 1.135, which suggesting that the stock is 13.542% more volatile than S&P 500. In comparison Cellectis SA has a beta of 3.275, suggesting its more volatile than the S&P 500 by 227.454%.

Genfit SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cellectis SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Genfit SA pays -- of its earnings as a dividend. Cellectis SA pays out -- of its earnings as a dividend.

Genfit SA quarterly revenues are --, which are smaller than Cellectis SA quarterly revenues of $12.7M. Genfit SA's net income of -- is lower than Cellectis SA's net income of $5.9M. Notably, Genfit SA's price-to-earnings ratio is 32.57x while Cellectis SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Genfit SA is 2.66x versus 3.01x for Cellectis SA. Usually stocks with elevated PS ratios are considered overvalued.

DBV Technologies SA has a net margin of -- compared to Genfit SA's net margin of --. Genfit SA's return on equity of -- beat DBV Technologies SA's return on equity of --.

Genfit SA has a consensus price target of $10.17, signalling upside risk potential of 186.94%. On the other hand DBV Technologies SA has an analysts' consensus of $22.63 which suggests that it could grow by 264.99%. Given that DBV Technologies SA has higher upside potential than Genfit SA, analysts believe DBV Technologies SA is more attractive than Genfit SA.

Genfit SA has a beta of 1.135, which suggesting that the stock is 13.542% more volatile than S&P 500. In comparison DBV Technologies SA has a beta of 0.707, suggesting its less volatile than the S&P 500 by 29.271%.

Genfit SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DBV Technologies SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Genfit SA pays -- of its earnings as a dividend. DBV Technologies SA pays out -- of its earnings as a dividend.

Genfit SA quarterly revenues are --, which are smaller than DBV Technologies SA quarterly revenues of --. Genfit SA's net income of -- is lower than DBV Technologies SA's net income of -$23M. Notably, Genfit SA's price-to-earnings ratio is 32.57x while DBV Technologies SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Genfit SA is 2.66x versus -- for DBV Technologies SA. Usually stocks with elevated PS ratios are considered overvalued.

NuCana PLC has a net margin of -- compared to Genfit SA's net margin of --. Genfit SA's return on equity of -- beat NuCana PLC's return on equity of --.

Genfit SA has a consensus price target of $10.17, signalling upside risk potential of 186.94%. On the other hand NuCana PLC has an analysts' consensus of $64.50 which suggests that it could grow by 4939.06%. Given that NuCana PLC has higher upside potential than Genfit SA, analysts believe NuCana PLC is more attractive than Genfit SA.

Genfit SA has a beta of 1.135, which suggesting that the stock is 13.542% more volatile than S&P 500. In comparison NuCana PLC has a beta of 0.892, suggesting its less volatile than the S&P 500 by 10.789%.

Genfit SA has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NuCana PLC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Genfit SA pays -- of its earnings as a dividend. NuCana PLC pays out -- of its earnings as a dividend.

Genfit SA quarterly revenues are --, which are smaller than NuCana PLC quarterly revenues of --. Genfit SA's net income of -- is lower than NuCana PLC's net income of -$836.1K. Notably, Genfit SA's price-to-earnings ratio is 32.57x while NuCana PLC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Genfit SA is 2.66x versus -- for NuCana PLC. Usually stocks with elevated PS ratios are considered overvalued.